IGF1 and benign prostatic hyperplasia: Also, androgen treatment induced prostatic hyperplasia in-vivo is dependent on increased expression of growth factors mainly IGF-1 and IGF-1R21 and increased expression of phosphorylated Akt as well as Bcl-222.